Medmix.Header.SkipLinkLabel

News

medmix veröffentlicht einen Halbjahresbericht und einen Jahresbericht.

news 1150x540
Ausgewählter Filter: Mehr anzeigen

AKTUELLE NEWS

AKTUELLE NEWS

medmix Drug Delivery (Haselmeier) and DCA Design International receive Red Dot Award for PiccoJect™ in the product design category

PiccoJect, the disposable, two-step autoinjector, designed for subcutaneous injection, has now been recognized for another prestigious design award, the Red Dot Award: Product Design 2023. The award will be presented to Haselmeier and DCA Design at the Red Dot Gala on June 19 in Essen, Germany.

6 April 2023

medmix wins landmark German court ruling on counterfeit static mixing

medmix, a global leader in high-precision delivery devices, has won a landmark court ruling in Germany to help protect its customers from counterfeit products. Found to be in breach of Unfair Competition Law, a distributor of cattle care products in Baden-Württemberg agreed to a Judgement by Acknowledgement at Cologne District Court for selling imitations of the patented Quadro™ static mixing tips, owned by medmix, type MFQ (Court ref: 84 O 131/22).

4 April 2023

medmix strengthens its sustainability commitments

medmix, global leader in high-precision delivery devices, is further strengthening its footprint in sustainable products and eco-design across all its segments, and delivers results. The company has committed to SBTi adopting the 1.5°C emission goal. It has successfully been assessed by CDP, and it has aligned with the UNGC principles. Separately, medmix has been awarded EcoVadis best-in-class ratings.

23 März 2023

medmix delivers growth in first full year of independent operations

Ad hoc announcement pursuant to Art. 53 LR

FULL YEAR 2022 HIGHLIGHTS

22 Februar 2023

medmix announces intention to sell entity in Poland and revises outlook for FY 2022

Ad hoc announcement pursuant to Art. 53 LR

medmix announces negotiations for the sale of its Polish entity, following its decision to stop production in Wroclaw, Poland. The company revises its outlook for FY 2022, reflecting the impact of mitigating sanctions in Poland, ongoing inflationary pressures, and mix.

11 Januar 2023

medmix continues expansion in Asia with a strategic acquisition for its Beauty segment in China

In line with its local for local growth strategy in China, medmix has signed an investment agreement to acquire a majority stake in Guangdong Qiaoyi Plastic Co. LTD, a beauty manufacturing business in Shantou.

9 Januar 2023

medmix Drug Delivery (Haselmeier): PiccoJect wins Good Design Award

medmix, global leader in high-precision delivery devices, won the prestigious Good Design™ Award 2022 in the Medical category for PiccoJect™, the autoinjector from medmix Drug Delivery (Haselmeier™). PiccoJect™ is a disposable two-step autoinjector designed for subcutaneous injection.

22 Dezember 2022

medmix prevents counterfeit Cox dispensers from entering UK supply chain

medmix works with a UK distributor to defend trademark rights and remove counterfeit products imitating its COXTM handheld sealant and adhesive dispensers from sale. Having successfully identified an illegal supply route, medmix now supports the distributor by providing an OEM supply of genuine, high-quality dispensers.

12 Dezember 2022

medmix Board of Directors nominate Rob ten Hoedt as proposed Chairman of the Board, for election at the AGM 2023

Ad hoc announcement pursuant to Art. 53 LR

30 November 2022

Unerlaubte Nachahmungen von Austraggeräten – medmix Schweiz verteidigt seine Rechte erfolgreich gegen Produktfälscher auf der International Hardware Fair 2022

Die medmix Switzerland AG ist Weltmarktführer für Design und Produktion von manuellen, batterie- und druckluftbetriebenen Austraggeräten für Dicht- und Klebstoffe. In den vergangenen Jahren wurden auf den relevanten Märkten fast identische Nachahmungen dieser Austraggeräte entdeckt. Diese tiefpreisigen Imitationen anderer Hersteller werden nicht mit den strengen Qualitätskontrollen von medmix hergestellt und sind nicht durch die Garantie von medmix geschützt.

3 November 2022

medmix Drug Delivery (Haselmeier™) and AARDEX® Group join Forces to Improve Self-Administration of Injectable Drugs in Clinical Trials

Stuttgart – medmix Drug Delivery (Haselmeier) and AARDEX Group announced today a collaboration, combining Haselmeier´s D-Flex™ Logbook with AARDEX Group’s Medication Adherence software and Hardware ecosystem.

3 November 2022

medmix announces significant expansion in manufacturing footprint, supporting its Industry segment and Healthcare business area

In line with its focus on establishing additional, cost-competitive manufacturing capacities, medmix has signed a business acquisition agreement for the entire plastics business of Universal de Suministros, S.L., Spain ("Universal").

29 August 2022